MedPath

Study for effectiveness of Nigella sativa (Black seed) in patients with dyspepsia

Phase 2
Conditions
on-ulcer dyspepsia.
Dyspepsia
Registration Number
IRCT138802061848N1
Lead Sponsor
King Faisal University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
110
Inclusion Criteria

1) Patients complaining of dyspeptic symptoms
2) Patients with positive result for H. pylori infection confirmed by both histopathology and rapid urease test (CLO test)

Exclusion criteria:
1) the endoscopy showed peptic ulcer, gastric cancer or other gastrointestinal bleeding
2) they had taken proton-pump inhibitors, bismuth or antibiotics in the last 4 weeks before endoscopy
3) pregnant or lactating
4) intolerant to therapeutic regimens

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradication of H. pylori. Timepoint: 4 weeks after the end of treatment. Method of measurement: Negative stool antigen by rapid monoclonal immunochromatographic method (ImmunoCard STAT! HpSA, Meridian Bioscience Europe).
Secondary Outcome Measures
NameTimeMethod
Improvment in dyspeptic symptoms (epigastric pain and reflux symptoms). Timepoint: 4 weeks after end of teatment. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath